BDBM50088504 Norvir Ritonavir ABBOTT-84538 A-84538 CHEBI:45409
CHEMBL163 Norvir Ritonavir RTV 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate ABT-538 BDBM520
- Qiao, J; Zhao, C; Liu, J; Du, Y Design and synthesis of selenazole-substituted ritonavir analogs. Bioorg Med Chem Lett 28: 2379-2381 (2018)
- Sevrioukova, IF; Poulos, TL Dissecting cytochrome P450 3A4-ligand interactions using ritonavir analogues. Biochemistry 52: 4474-81 (2013)
- Kharasch, ED; Mitchell, D; Coles, R; Blanco, R Rapid clinical induction of hepatic cytochrome P4502B6 activity by ritonavir. Antimicrob Agents Chemother 52: 1663-9 (2008)
- Sevrioukova, IF; Poulos, TL Pyridine-substituted desoxyritonavir is a more potent inhibitor of cytochrome P450 3A4 than ritonavir. J Med Chem 56: 3733-41 (2013)
- Samuels, ER; Sevrioukova, IF An increase in side-group hydrophobicity largely improves the potency of ritonavir-like inhibitors of CYP3A4. Bioorg Med Chem 28: (2020)
- Kempf, DJ; Sham, HL; Marsh, KC; Flentge, CA; Betebenner, D; Green, BE; McDonald, E; Vasavanonda, S; Saldivar, A; Wideburg, NE; Kati, WM; Ruiz, L; Zhao, C; Fino, L; Patterson, J; Molla, A; Plattner, JJ; Norbeck, DW Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy. J Med Chem 41: 602-17 (1998)
- Kempf, DJ; Molla, A; Marsh, KC; Park, C; Rodrigues, AD; Korneyeva, M; Vasavanonda, S; McDonald, E; Flentge, CA; Muchmore, S; Wideburg, NE; Saldivar, A; Cooper, A; Kati, WM; Stewart, KD; Norbeck, DW Lack of stereospecificity in the binding of the P2 amino acid of ritonavir to HIV protease Bioorg Med Chem Lett 7: 699-704 (1997)
- Kumar, S; Kwei, GY; Poon, GK; Iliff, SA; Wang, Y; Chen, Q; Franklin, RB; Didolkar, V; Wang, RW; Yamazaki, M; Chiu, SH; Lin, JH; Pearson, PG; Baillie, TA Pharmacokinetics and interactions of a novel antagonist of chemokine receptor 5 (CCR5) with ritonavir in rats and monkeys: role of CYP3A and P-glycoprotein. J Pharmacol Exp Ther 304: 1161-71 (2003)